157 related articles for article (PubMed ID: 2418162)
1. Phase I trials of poly(I,C) complexes in advanced cancer.
Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
[TBL] [Abstract][Full Text] [Related]
2. A phase I evaluation of poly(I,C)-LC in cancer patients.
Stevenson HC; Abrams PG; Schoenberger CS; Smalley RB; Herberman RB; Foon KA
J Biol Response Mod; 1985 Dec; 4(6):650-5. PubMed ID: 2418163
[TBL] [Abstract][Full Text] [Related]
3. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma.
Hawkins MJ; Levin M; Borden EC
J Biol Response Mod; 1985 Dec; 4(6):664-8. PubMed ID: 2418164
[TBL] [Abstract][Full Text] [Related]
4. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of poly(I,C)-LC in cancer patients.
Maluish AE; Reid JW; Crisp EA; Overton WR; Levy H; Foon KA; Herberman RB
J Biol Response Mod; 1985 Dec; 4(6):656-63. PubMed ID: 4087034
[TBL] [Abstract][Full Text] [Related]
6. Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.
Durie BG; Levy HB; Voakes J; Jett JR; Levine AS
J Biol Response Mod; 1985 Oct; 4(5):518-24. PubMed ID: 3935757
[TBL] [Abstract][Full Text] [Related]
7. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
[TBL] [Abstract][Full Text] [Related]
9. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
Levine AS; Sivulich M; Wiernik PH; Levy HB
Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].
Chirigos MA; Schlick E; Ruffmann R; Budzynski W; Sinibaldi P; Gruys E
J Biol Response Mod; 1985 Dec; 4(6):621-7. PubMed ID: 4087033
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
13. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
McFarlin DE; Bever CT; Salazar AM; Levy HB
J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
[TBL] [Abstract][Full Text] [Related]
14. The effect of interferon on rabies infection of animals.
Baer GM
Tex Rep Biol Med; 1981-1982; 41():526-31. PubMed ID: 6189218
[No Abstract] [Full Text] [Related]
15. Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
Talmadge JE; Hartmann D
J Biol Response Mod; 1985 Oct; 4(5):484-9. PubMed ID: 4078594
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid.
Droller MJ
J Urol; 1987 Feb; 137(2):202-6. PubMed ID: 3806804
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
J Biol Response Mod; 1985 Oct; 4(5):531-7. PubMed ID: 2416884
[TBL] [Abstract][Full Text] [Related]
18. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
Levy HB; Riley FL; Lvovsky E; Stephen EE
Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
20. Liver enzyme abnormalities after poly ICLC infusions.
Hess WA; Bever CT; McFarlin DE
Cancer Treat Rep; 1985 Nov; 69(11):1342. PubMed ID: 2418967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
